ストックスクリーナーアプリを入手
4.635
1.85%
0.085
前日終値:
$4.55
開ける：
$4.55
24時間の取引高:
209.74K
Relative Volume:
0.15
時価総額：
$1.78B
収益：
$775.09M
当期純損益:
$-58.68M
株価収益率:
-34.95
EPS:
-0.1326
ネットキャッシュフロー:
$64.06M
1週間 パフォーマンス:
-3.26%
1か月 パフォーマンス:
-5.24%
6か月 パフォーマンス:
-30.84%
1年 パフォーマンス:
-34.36%
1日の値動き範囲:
$4.54
$4.68
1週間の範囲:
$4.54
$4.945
52週間の値動き範囲:
$4.09
$9.2599
Goodrx Holdings Inc Stock (GDRX) Company Profile
名前
Goodrx Holdings Inc
セクター
電話
(855) 268-2822
住所
2701 OLYMPIC BOULEVARD, SANTA MONICA
GDRX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.6342 | 1.78B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
238.38 | 38.81B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
74.78 | 12.84B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
64.93 | 12.45B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
56.78 | 10.16B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
90.50 | 7.83B | 1.15B | 96.70M | -161.99M | 1.09 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-08-09 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | アップグレード | JP Morgan | Neutral → Overweight |
| 2024-02-26 | 開始されました | Leerink Partners | Outperform |
| 2024-01-02 | ダウングレード | BofA Securities | Buy → Underperform |
| 2023-08-10 | アップグレード | DA Davidson | Neutral → Buy |
| 2023-07-31 | アップグレード | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | 開始されました | Citigroup | Buy |
| 2022-11-04 | アップグレード | JP Morgan | Underweight → Neutral |
| 2022-09-16 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | 開始されました | Truist | Hold |
| 2022-08-12 | 開始されました | DA Davidson | Neutral |
| 2022-06-10 | ダウングレード | Goldman | Buy → Neutral |
| 2022-06-06 | 再開されました | BofA Securities | Buy |
| 2022-06-01 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2022-05-10 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | ダウングレード | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | 開始されました | Wells Fargo | Equal Weight |
| 2022-04-07 | 開始されました | Guggenheim | Buy |
| 2022-04-01 | 再開されました | Credit Suisse | Neutral |
| 2022-03-15 | アップグレード | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | 繰り返されました | Barclays | Overweight |
| 2022-03-01 | 繰り返されました | BofA Securities | Neutral |
| 2022-03-01 | ダウングレード | Cowen | Outperform → Market Perform |
| 2022-03-01 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | 繰り返されました | Evercore ISI | Outperform |
| 2022-03-01 | 繰り返されました | Goldman | Buy |
| 2022-03-01 | 繰り返されました | JP Morgan | Underweight |
| 2022-03-01 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2022-03-01 | 繰り返されました | SVB Leerink | Outperform |
| 2022-01-07 | 開始されました | Goldman | Buy |
| 2021-12-21 | 開始されました | Stephens | Overweight |
| 2021-12-02 | 開始されました | Jefferies | Buy |
| 2021-08-31 | アップグレード | Barclays | Equal Weight → Overweight |
| 2021-08-13 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | 開始されました | Robert W. Baird | Neutral |
| 2021-04-06 | 再開されました | Evercore ISI | Outperform |
| 2021-01-25 | 開始されました | Guggenheim | Buy |
| 2020-11-19 | アップグレード | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | ダウングレード | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | 開始されました | Barclays | Equal Weight |
| 2020-10-19 | 開始されました | BofA Securities | Neutral |
| 2020-10-19 | 開始されました | Citigroup | Buy |
| 2020-10-19 | 開始されました | Cowen | Outperform |
| 2020-10-19 | 開始されました | Credit Suisse | Outperform |
| 2020-10-19 | 開始されました | Deutsche Bank | Hold |
| 2020-10-19 | 開始されました | Goldman | Neutral |
| 2020-10-19 | 開始されました | JP Morgan | Neutral |
| 2020-10-19 | 開始されました | Morgan Stanley | Overweight |
| 2020-10-19 | 開始されました | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | 開始されました | SVB Leerink | Outperform |
| 2020-10-19 | 開始されました | UBS | Buy |
すべてを表示
Goodrx Holdings Inc (GDRX) 最新ニュース
Do Fundamentals Have Any Role To Play In Driving GoodRx Holdings, Inc.'s (NASDAQ:GDRX) Stock Up Recently? - Simply Wall St
GoodRx: Great Value For Patient Investors (Upgrade) (NASDAQ:GDRX) - Seeking Alpha
PBMs Hit With Antitrust Suit Over GoodRx Generics Program - Law360
GoodRx Strengthens Leadership: $100M Revenue Leader Takes President Role - StockTitan
GoodRx Holdings, Inc. (NASDAQ:GDRX) Shares Sold by US Bancorp DE - Defense World
GoodRx Holdings, Inc. (GDRX): Why Are Hedge Funds Bullish On This Cash-Rich Penny Stock? - Insider Monkey
GoodRx Holdings, Inc. (GDRX): Among the Cash-Rich Small Cap Stocks To Invest In According To Analysts - Insider Monkey
GoodRx Holdings, Inc. (NASDAQ:GDRX) Receives Average Recommendation of “Moderate Buy” from Brokerages - Defense World
12 Cash-Rich Penny Stocks To Buy According To Hedge Funds - Insider Monkey
Shareholders of GoodRx Holdings, Inc. Should Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your RightsGDRX - ACCESS Newswire
Investors in GoodRx Holdings, Inc. Should Contact Levi & Korsinsky Before June 21, 2024 to Discuss Your RightsGDRX - ACCESS Newswire
Wells Fargo & Company Cuts GoodRx (NASDAQ:GDRX) Price Target to $8.00 - Defense World
Levi & Korsinsky Notifies Shareholders of GoodRx Holdings, Inc.(GDRX) of a Class Action Lawsuit and an Upcoming Deadline - ACCESS Newswire
Levi & Korsinsky Notifies GoodRx Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineGDRX - ACCESS Newswire
GoodRx Holdings, Inc. (GDRX) Q4 Earnings Match Estimates - MSN
GoodRx Holdings, Inc. (NASDAQ:GDRX) Q4 2024 Earnings Call Transcript - MSN
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of GoodRx Holdings, Inc.(GDRX) Shareholders - ACCESS Newswire
The Analyst Verdict: GoodRx Holdings In The Eyes Of 4 Experts - Benzinga
Investors who lost money on GoodRx Holdings, Inc.(GDRX) should contact Levi & Korsinsky about pending Class ActionGDRX - ACCESS Newswire
GoodRx Holdings Leads The Charge With These 3 Promising Penny Stocks - Simply Wall St
Decoding GoodRx Holdings Inc (GDRX): A Strategic SWOT Insight - GuruFocus.com
GoodRx Reports Mixed Q4: Pharma Strength Amid Subscription Decline, Sluggish Prescription Sales - Benzinga India
GoodRx Holdings Inc (GDRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and ... - Yahoo Finance
GoodRx Holdings Reports Strong 2024 Financial Results - TipRanks
GoodRx Earnings Call: Growth Amid Challenges - TipRanks
Citi raises GoodRx stock target to $6.75, maintains buy rating By Investing.com - Investing.com South Africa
GoodRx Holdings IncOrdinary SharesClass A to Host Earnings Call - ACCESS Newswire
Citi raises GoodRx stock target to $6.75, maintains buy rating - Investing.com
Insights Into GoodRx (GDRX) Q4: Wall Street Projections for Key Metrics - MSN
Raymond James Reiterates Strong Buy Rating on GoodRx Holdings Inc. (GDRX) - StreetInsider.com
GoodRx Holdings Inc. (GDRX) PT Raised to $6.75 at Citi - StreetInsider.com
GoodRx shares rise on upbeat Q1 guidance despite Q4 miss By Investing.com - Investing.com Australia
Earnings call transcript: GoodRx Q4 2024 misses EPS forecast, stock rises - Investing.com
GoodRx Holdings Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Here's What Key Metrics Tell Us About GoodRx (GDRX) Q4 Earnings - Yahoo Finance
GoodRx Q4 Adjusted Earnings, Revenue Rise; Q1, 2025 Revenue Guidance Issued - Marketscreener.com
GoodRx Reports Fourth Quarter and Full Year 2024 Results - 01Net
GoodRx Holdings Sees Increased Revenue In Q1, Full YearUpdate - Nasdaq
GOODRX Earnings Results: $GDRX Reports Quarterly Earnings - Nasdaq
BRIEF-GoodRx Holdings Q4 Adjusted Net Income USD 34.7 Million Vs. IBES Estimate USD 37.4 Million - TradingView
GoodRx Holdings, Inc. (GDRX) Misses Q4 EPS by 1c ; Offers Guidance - StreetInsider.com
GoodRx Earnings: What To Look For From GDRX By Stock Story - Investing.com Canada
GoodRx Earnings: What To Look For From GDRX - The Globe and Mail
GoodRx Holdings Inc (GDRX) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
GoodRx’s SWOT analysis: prescription savings leader faces pharmacy headwinds - Investing.com
GoodRx Holdings Inc expected to post earnings of 10 cents a shareEarnings Preview - TradingView
Goodrx Holdings Inc (GDRX) 財務データ
収益
当期純利益
現金流量
EPS
1.05%
0.92%
大文字化:
|
ボリューム (24 時間):